Cross-protective efficacy of the AVAC ASF LIVE vaccine against recombinant rASFV I,II strain
Update: 22/8/2026 | 4:02:48 PM
A scientific study conducted by AVAC Vietnam Joint Stock Company, published in the Journal of Veterinary Science and Technology, Vol. XXXIII, No. 2, 2026
Nguyen Van Diep¹*, Nguyen Van Duc¹, Vu Xuan Dang¹, Nguyen Thi Ngoc¹, Do Phuc Tue¹, Tran Ngoc Tiep¹, Pham Ngoc Doanh²
Corresponding author: Nguyen Van Diep
Email: diepnv@avac.com.vn
Full-text article: Cross-protective efficacy of the AVAC ASF LIVE vaccine against recombinant rASFV I,II strain
Other news
- Evaluating the safety and effectiveness of the AVAC ASF LIVE vaccine against African swine fever under field conditions
- Evaluation of the persistence of AVAC ASF LIVE vaccine virus
- AVAC Vietnam JSC Makes a Strong Impression at IPVS 2026
- AVAC VIETNAM AT ILDEX VIETNAM 2026
- Vietnam's homegrown asf vaccine reaches global markets
- Vaccine export emerges as highlight of Vietnam’s agriculture
- Việt Nam accelerates progress in veterinary vaccine production
- Household pig farming has lifeline thanks to ASF vaccine: Practical results will convince farmers to use
- Pig farming households gain a new lifeline with ASF vaccine
- ASF shot - is it really safe and effective? - Feedback from users
